Assenagon Asset Management S.A. Has $2.25 Million Stake in AngioDynamics, Inc. (NASDAQ:ANGO)

Assenagon Asset Management S.A. lowered its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 11.9% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 239,881 shares of the medical instruments supplier's stock after selling 32,426 shares during the period. Assenagon Asset Management S.A. owned approximately 0.59% of AngioDynamics worth $2,252,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of the stock. Divisadero Street Capital Management LP bought a new stake in shares of AngioDynamics in the 4th quarter valued at $4,714,000. Segall Bryant & Hamill LLC increased its holdings in shares of AngioDynamics by 55.3% in the fourth quarter. Segall Bryant & Hamill LLC now owns 1,415,156 shares of the medical instruments supplier's stock worth $12,963,000 after acquiring an additional 503,713 shares in the last quarter. Marshall Wace LLP raised its position in shares of AngioDynamics by 1,335.1% during the fourth quarter. Marshall Wace LLP now owns 476,824 shares of the medical instruments supplier's stock worth $4,368,000 after purchasing an additional 443,598 shares during the period. Paradigm Capital Management Inc. NY acquired a new stake in shares of AngioDynamics during the fourth quarter worth about $3,701,000. Finally, Nuveen Asset Management LLC lifted its holdings in shares of AngioDynamics by 37.4% during the 4th quarter. Nuveen Asset Management LLC now owns 1,296,366 shares of the medical instruments supplier's stock valued at $11,875,000 after purchasing an additional 353,070 shares in the last quarter. 89.43% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, HC Wainwright restated a "buy" rating and set a $16.00 price objective (up from $15.00) on shares of AngioDynamics in a report on Monday, April 7th.

AngioDynamics Stock Down 2.1%

Shares of NASDAQ ANGO traded down $0.21 during mid-day trading on Friday, reaching $10.02. 369,919 shares of the company were exchanged, compared to its average volume of 629,765. The stock has a market capitalization of $406.84 million, a P/E ratio of -9.95 and a beta of 0.62. The company's 50-day simple moving average is $9.79 and its 200-day simple moving average is $9.94. AngioDynamics, Inc. has a twelve month low of $5.47 and a twelve month high of $13.50.

AngioDynamics (NASDAQ:ANGO - Get Free Report) last posted its quarterly earnings data on Wednesday, April 2nd. The medical instruments supplier reported $0.03 earnings per share for the quarter, topping the consensus estimate of ($0.13) by $0.16. AngioDynamics had a negative return on equity of 3.73% and a negative net margin of 14.61%. The firm had revenue of $72.00 million for the quarter, compared to analysts' expectations of $70.30 million. The business's revenue was down 4.3% compared to the same quarter last year. As a group, equities research analysts expect that AngioDynamics, Inc. will post -0.37 EPS for the current year.

AngioDynamics Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.